Featured Content
A $7.4 billion bankruptcy settlement tied to Purdue Pharma will exclude tens of thousands of opioid claimants, with fewer than…
Most Read
The Latest
Join two leading cardiovascular experts for an in-depth webinar on the emerging role of lipoprotein(a) [Lp(a)] in aortic stenosis and peripheral arterial disease (PAD). The session will explore the underlying pathophysiology, examine how Lp(a) contributes to disease progression, and highlight…
On Demand
Presented by:
Presenters
Dr. Marc P. Bonaca MD, MPH, FACC, FAHA
Executive Director of Colorado Prevention Center, Aurora, CO, USA Director of Vascular Research, Tenured Professor of Medicine, University of Colorado Anschutz, Aurora, CO, USA Chair of the AHA PAD Collaborative Past Chair of the ACC Vascular Disease Section Leadership Council
Nishant Shah, MD
Assistant Professor, Medicine and Cardiovascular Disease Prevention Lead for the Duke Health System Remote Lipid Monitoring Program Clinical lead in the implementation of Inclisiran across Duke Health System DCRI for a study that evaluates the effectiveness of PCSK9 inhibitors in the Prevention of Cardiovascular Disease
Join two nationally recognized Lp(a) experts for an in-depth discussion on the evolving landscape of Lp(a) testing and management. Drawing on clinical experience from Mayo Clinic and NYU Langone, this session will provide a comprehensive overview of the structural and…
On Demand
Presented by:
Presenters
Howard S. Weintraub, MD, FACC, FAHA, FASPC
Clinical Professor of Medicine, NYU Grossman School of Medicine Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
Leslie J. Donato, Ph.D., D(ABCC)
Co-Director Clinical Specialty Laboratory Co-Director Hospital Clinical Laboratory and Point of Care Associate Professor, Laboratory Medicine and Pathology Department of Laboratory Medicine and Pathology at Mayo Clinic
U.S. hospitals are under pressure from every direction — cost constraints, supply chain instability, cybersecurity threats and the push to integrate AI responsibly. The question isn’t whether to adapt. It’s how. In this webinar a global medtech CEO shares how…
Presented by:
Presenters
Britt Meelby Jensen
CEO, Ambu
Many DSOs have already invested in automation. Few have figured out how to manage it at scale. What worked across five locations often breaks at 50. As multi-site organizations grow, inconsistent workflows across patient and payer payment processes, limited visibility…
Presented by:
Presenters
James Swan, MBA
Sr. Director, Enterprise Solutions, Rectangle Health
York, Pa.-based WellSpan Health launched a 24-hour operated behavioral health walk-in crisis center April 27. The center aims to serve as an alternative to emergency department visits with on-site evaluations, stabilization services and referrals for ongoing care, according to an…
The Trump administration is working to reinstate the 988 Suicide and Crisis Lifeline’s specialized support option for LGBTQ+ callers, HHS Secretary Robert F. Kennedy Jr. said during a Senate hearing, Medpage Today reported April 24. The administration removed the tailored…
Psychedelics are gaining the attention of the federal government as a potential treatment for complex mental health conditions, but healthcare leaders remain divided on their readiness for broader clinical use. While some see promise for patients with treatment-resistant conditions, others…
Controlled substance waste is one of the most overlooked cost centers in hospital pharmacy. Each waste event represents not just a lost dose, but lost nursing time, compliance overhead and real diversion risk. A recent multi-site study quantified the problem:…
On Demand
Presented by:
Presenters
Matthew Gimbar, PharmD
Senior Associate Director, Pharmacy Operations, University of Illinois Hospital and Health Sciences Syste
Paul Stranges, PharmD, MSHI, BCACP, AE-C, FCCP
Assistant Director, Opioid Stewardship & Drug Diversion, University of Illinois Hospital and Health Sciences System
John Hertig, PharmD, MS, CPPS, FASHP, FFIP
Founder and President, Hertig Healthcare Advising
UCLA Health researchers are developing wearable technology to detect early signs of autism and other developmental conditions in infants. The project, supported by a $3.1 million grant from the National Institute of Neurologic Disorders and Stroke, will test wearable sensors…
Between the July 2022 launch of the 988 Suicide and Crisis Lifeline and December 2024, 35,529 suicides were observed compared to 39,901 expected, representing an 11% reduction, or 4,372 fewer deaths, according to an April 22 research letter published in JAMA. …
Popular in Behavioral Health News
Becker’s offerings
-
Events
Where healthcare leaders meet — see what’s coming up.
View All Events
-
Webinars
Explore and register for webinars across a wide variety of topics.
View All Webinars
-
Whitepapers
Gain valuable insights & knowledge from our leading industry experts.
View All Whitepapers
-
Podcasts
Listen to interviews and conversations on healthcare’s most pressing issues.
View All Podcasts